Molecule intelOpportunity: StrongEssential

Hydralazine

11 brands · 4 companies · product forms

ATC: C02DB02 1 DRAP alert

Opportunity snapshot

Launch attractiveness
60
Market saturation
11
Price room
52
Regulatory risk
50
11
brands
4
companies
Rs 52.27
median price
12
price points
3.1x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 36%

Price room

Across observed sources and strengths
CheapestRs 33.95
MedianRs 52.27
Most expensiveRs 105.08
Spread3.1×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 3.10x across 12 trusted points (Rs 33.95-105.08). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 3 live products for Hydralazine — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2023-02-23
Recall Alert: Drug Product; Hydralazine 25mg Tablets (Batch # 257) by M/s Zafa Pharmaceuti

Why this score

Launch attractiveness

40% supply-gap(57) + 25% price-variation(52) + 20% low-competition(89) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

4 canonical companies and 11 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 3.10x across 12 trusted points (Rs 33.95-105.08). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2023-02-23 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.